Catalent to buy Cook Pharmica for $950m in cash
Catalent Inc has announced it will buy Cook Pharmica for $950m (€792m) in cash to boost its high tech drug production business.
Archives for September 18, 2017
update
US FDA issues Dr Reddy's with Form 483 for UK plant
The US Food and Drug Administration (FDA) has found problems at a Dr Reddy’s API plant in the UK.
GSK outlines multi-site plan for new US COPD med Trelegy Ellipta
The APIs for the newly US approved three-in-one COPD drug Trelegy Ellipta will be made at facility in Singapore according to GSK.
Brammer ups early phase manufacturing capacity
Brammer Bio has doubled its early phase manufacturing capacity at its Alachua, Florida-based site.
Puracap's Wuhan site passes US FDA inspection prompted by ANDA
US regulators are satisfied a soft gelatin capsule plant in Wuhan, China is up to code according to Puracap Pharmaceutical LLC.
Dry powder development: Vectura’s BI alternative backed by Pulmatrix
Vectura has advanced plans to develop a dry powder inhaler to treat patients with chronic obstructive pulmonary disease (COPD) for the US market.
Althea opens new GMP production suite
Ajinomoto Althea, Inc. has opened a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility in San Diego, CA.
Fire ant venom to combat thick skin
Researchers say compounds from fire ant venom could be used to develop psoriasis treatments which limit skin-thickening side effects.